Trial intelligence / Profile preview

Misoprostol for Intraoperative Bleeding in Myomectomy

NCT02061657Phase 3Completed

Sponsor
Ain Shams University
Start
Jun 2013
Primary completion
Jun 2014
Modality
Small Molecules
Countries
1
01

Overview

Phase 3, randomised, double-blind trial in leiomyoma comparing Misoprostol Group with Placebo Group (2 arms). Primary endpoint: Intraoperative blood loss at 1 hour. Started Jun 2013; status: completed.

02

Drugs

misoprostol
03

Conditions

leiomyoma

Beyond the preview

Go deeper on NCT02061657.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02061657.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call